Kliiniset tutkimukset Nct sivu
Clinical Trial Results:
A Phase III, 18 Month, Multicenter, Randomized, Double-Blind, Active-Controlled Clinical Trial to Compare Rosiglitazone versus Glipizide on the Progression of Atherosclerosis in Subjects with Type 2 Diabetes Mellitus and Cardiovascular Disease
| Summary | |
EudraCT number | 2004-004090-29 |
Trial protocol | SE DE LV IT CZ GR ES |
Global completion date | 08 Aug 2008 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 16 Feb 2016 |
First version publication date | 13 Nov 2014 |
Other versions | |
Summary report(s) | AVD100521-FDAAA-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.